Reduction of restenosis
OwnerWerner Krauseinventor
Life of this patent
Estimating the term…
Abstract
A method of reducing restenosis comprises administering to a patient a stent and reducing, shutting down or modifying functioning of the immune system in a controlled manner. In a preferred embodiment T-cell depletion or T-cell modification is used for controlling the immune system. The T-cell depletor or T-cell modifier is administered either separately or as part of the stent. Alternatively, an ex-vivo procedure may be used.
Claims26
A method of reducing restenosis comprising administering to a patient a stent and temporarily shutting down or reducing the functionality of the immune system either locally or in the whole organism.
A method of reducing restenosis comprising administering to a patient a stent and depleting the T-cells of said patient or modiying their functionality.
A method of reducing restenosis comprising administering to a patient a stent and a T-cell depletor or a T-cell modifier that reduces the functionality of T-cells.
Dependencies are inferred from the claim text.